Sociedad Americana de Hirudoterapia

Destructive Mold Osteomyelitis of the Wrist Caused by Scedosporium - A Case Report

Bo C, Conen A, Giacalone M, Marti R, Grobholz R, Seeger H, Klein HJ, Plock JA, Frueh FS (2026) · Journal of Clinical Medicine · n=1

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidenceCondition: Venous Congestion in Surgical Flaps
Sample size of this trial compared with other Venous Congestion in Surgical Flaps trialsHuang D 20221232Valdes CA 2023313Hamzah M 2023225Iaprintsev V 202575Trigonis R 202142McMichael A 202430Engel ER 202422Sonmez E 201120Brandewie K 202410Bo C 20261
This trial (highlighted) by sample size alongside other indexed Venous Congestion in Surgical Flaps trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-patient case report (68-year-old kidney-pancreas transplant recipient with Scedosporium chronic wrist osteomyelitis, Kantonsspital Aarau, Switzerland)
Sample size (n)
1
Intervention
Multistage hand salvage with osteocutaneous triple-barrel fibula flap reconstruction; postoperative leech therapy for fibula skin island venous congestion; salvage attempt failed due to subsequent multi-resistant Klebsiella and Acinetobacter infection requiring transradial amputation
Comparator
Conventional reconstructive options without leech adjunct
Primary endpoint
Hand salvage feasibility in immunocompromised host with Scedosporium osteomyelitis
Primary result
Initial reconstruction with leech-supported flap survival, but multi-resistant Gram-negative infection caused flap necrosis and ultimate transradial amputation; case highlights balance of limb salvage vs amputation in complex immunocompromised hosts
Follow-up duration
Multistage operative course through amputation decision

Key Findings

  • Chronic wrist Scedosporium osteomyelitis in kidney-pancreas transplant recipient
  • Triple-barrel fibula flap reconstruction with leech adjunct
  • Multi-resistant Klebsiella and Acinetobacter caused flap loss
  • Ultimate transradial amputation despite multistage salvage
  • Limb salvage decision-making framework

Limitations

  • Single case in extremely immunocompromised host
  • Cannot generalize from Scedosporium mold context
  • Multi-resistant infection separate from leech use
  • Cannot quantify leech contribution to initial flap survival
  • Outcomes biased by underlying host immunocompromise

Clinical Implications

Bo 2026 illustrates leech therapy's contribution to ambitious multistage hand salvage in immunocompromised transplant recipients with chronic mold osteomyelitis. For US clinicians under K040187, this case demonstrates that while leech support enables initial flap survival in compromised hosts, fundamentally adverse infectious and immune conditions may still lead to amputation - reinforcing that leech therapy is one tool in complex reconstructive decision-making.

Related Trials

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.